Filing Details
EXOZYMES INC. (NASDAQ:EXOZ) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
8k filedNASDAQ:EXOZ
EXOZYMES INC. (EXOZ) Reports Material Event to SEC
EXOZYMES INC. (NASDAQ:EXOZ) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
At publication ·
What changed
EXOZYMES INC. (NASDAQ:EXOZ) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- EXOZYMES INC. filed a Form 8-K with the SEC on October 09, 2026, disclosing a material event that shareholders should know about.
- The company's stock trades at $5.25 with a market capitalization of $134.1 million.
- Material events reported on Form 8-K can include leadership changes, agreements, acquisitions, asset sales, or financial guidance changes.
Market Context
EXOZYMES INC.'s stock currently trades at $5.25 with a market capitalization of $134.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for EXOZYMES INC.'s stock.
All SEC filings for EXOZYMES INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View EXOZ Stock Page
Frequently Asked Questions
Where can I read EXOZ's SEC filings?
Browse all filings on our EXOZ SEC filings page.
What types of SEC filings does EXOZYMES INC. file?
Public companies like EXOZYMES INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.